Description

Priority Review is a fast-track status granted to eligible new drug submissions for human use, following review and approval of a request submitted by the sponsor of the drug. Priority Review submissions are introduced into Health Canada's drug review queue in accordance with an accelerated review target of 180 days.

Resources

Name	Format	Description	Link
Priority Review of Drug Submissions (Therapeutic Products)	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fact-sheets/priority-review-drug-submissions-therapeutic-products.html
Priority Review of Drug Submissions (Therapeutic Products)	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/feuillets-information/evaluation-prioritaire-presentations-drogues-produits-therapeutiques.html

Tags

Topics

Categories